Israel’s Amorphical (see here previously) has adapted its amorphous calcium carbonate production technology to treat inflammatory diseases such as Crohn’s disease, multiple sclerosis, and arthritis. The mineral neutralizes the acidity within affected tissue to prevent inflammation. https://nocamels.com/category/news-briefs/#post-125592

Ziv Medical Center in Tzfat (Safed) is currently offering AMOR-18 from Israel’s Amorphical (see here previously) to all moderate to serious COVID-19 patients. It is also undergoing clinical trials at four Israeli hospitals. All 18 patients in Ziv’s trials of … Continue reading →

18 COVID-19 patients hospitalized with moderate or severe symptoms were treated with Amor-18 from Israel’s Amorphical (see here previously). All recovered and were discharged in a few days. https://www.jpost.com/health-and-wellness/coronavirus/article-689543 https://www.amorphical.com/ongoing-clinical-research/

I reported previously (twice) about Israel’s Amorphical which has developed amorphous calcium to treat osteoporosis in patients who have trouble absorbing current (crystalline) calcium supplements.  Amorphous calcium also reduces the acidity that certain enzymes use to generate cancer cells. https://www.youtube.com/embed/SIkxWsDqAM0?rel=0

Israel’s Amorphical has successfully completed a clinical trial of its amorphous calcium. The trial found that the patients’ absorption of amorphous calcium was double the average absorption of crystalline calcium. Amorphical aims to develop a product as a nutritional supplement. … Continue reading →

(Thanks to Uri) Israeli biotech Amorphic has developed Amorphous Calcium Carbonate (ACC) that the body absorbs far better than the crystalline form. Amorphic produced synthetic ACC after studying the crayfish, which uses natural ACC to build its bones in low … Continue reading →